UOMi005-A

Cell Line

Provider

External Databases

General Information

• Lester Sequiera G et al. Generation and Evaluation of Isogenic iPSC as a Source of Cell Replacement Therapies in Patients with Kearns Sayre Syndrome. Cells. 2021 Mar 5;10(3).
• Srivastava A et al. Human induced pluripotent stem cell (hiPSC) line UOMi006-A derived from PBMCs of a patient with Kearns-Sayre syndrome. Stem cell research. 2021 May;53:102355.
• Srivastava A et al. Generation of human induced pluripotent stem cell (hiPSC) line UOMi005-A from PBMCs of a patient with Kearns-Sayre syndrome. Stem cell research. 2021 May;53:102283.
• Rafieerad A et al. Development of Fluorine-Free Tantalum Carbide MXene Hybrid Structure as a Biocompatible Material for Supercapacitor Electrodes. Advanced functional materials. 2021 Jul 23;31(30):2100015.
• Srivastava A et al. Establishment of a new human iPSC cell line (UOMi007-A) from a patient with Hypophosphatasia. Stem cell research. 2022 Aug;63:102839.
• Adelipour M et al. The role of autophagy in the metabolism and differentiation of stem cells. Biochimica et biophysica acta. Molecular basis of disease. 2022 Aug 1;1868(8):166412.
• Srivastava A et al. Reprogramming of Hypophosphatasia patient cells to generate a new human iPSC cell line (UOMi009-A). Stem cell research. 2022 Oct;64:102921.
• Srivastava A et al. Generation of new human iPSC cell line (UOMi008-A) from a Hypophosphatasia patient. Stem cell research. 2022 Oct;64:102891.
• Chen Chao et al. Induced pluripotent stem cells: ex vivo models for human diseases due to mitochondrial DNA mutations. Journal of Biomedical Science. 2023-09-22.
• Yazdani Mazyar. Cellular and Molecular Responses to Mitochondrial DNA Deletions in Kearns-Sayre Syndrome: Some Underlying Mechanisms. Molecular Neurobiology. 2024-01-15.

General